Total knee arthroplasty under quadruple nerve block with ropivacaine 0.32%: effect of addition of intravenous dexmedetomidine to intravenous dexamethasone on analgesic duration
- 21 October 2020
- journal article
- research article
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 46 (2) , 104-110
Abstract
Background and objectives Peripheral nerve blocks reduce postoperative pain and enhance recovery after total knee arthroplasty (TKA). This study aims to assess the benefits of addition of intravenous dexmedetomidine (DexM) to intravenous dexamethasone on the analgesic duration of quadruple nerve blocks. Methods This double-blind, randomized, controlled trial prospectively enrolled 90 patients scheduled for TKA under quadruple nerve blocks (sciatic, femoral, obturator, and lateral femoral cutaneous nerves blocks) with 70 mL, 0.32% ropivacaine. All patients received systemic dexamethasone 10 mg. Patients were randomized to receive DexM (2 µg/kg, intravenous) or placebo (1:1 ratio). The primary endpoint was the duration of analgesia defined as the time to first request for rescue analgesia (oxycodone). Results Kaplan-Meier curves for the first analgesic request were similar between groups (log-rank test; p=0.27). Median (IQR) duration of analgesia was similar between placebo (1575 min (1211–1952)) and DexM (1470 min (1263–1700)) groups (p=0.56). Cumulative consumption of oxycodone at the 48th hour was 20 mg (10–30) and 30 mg (20–40) in placebo and DexM groups, respectively (p=0.14). The day after surgery, 93% and 89% of patients were able to walk in placebo and DexM groups, respectively (p=0.46). Intravenous DexM was associated with bradycardia, hypotension and longer recovery room stay (pConclusions In a multimodal analgesic regimen, addition of systemic DexM (2 µg/kg) to systemic dexamethasone does not prolong the analgesic duration of quadruple nerve block with ropivacaine 0.32% after TKA. Trial registration number NCT03834129.Keywords
This publication has 27 references indexed in Scilit:
- Pain Management Modalities after Total Knee ArthroplastyAnesthesiology, 2017
- The impact of peripheral nerve blocks on perioperative outcome in hip and knee arthroplasty—a population-based studyPain, 2016
- Dexmedetomidine during total knee arthroplasty performed under spinal anesthesia decreases opioid use: a randomized-controlled trialCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2016
- Use of Peripheral Nerve Blocks with Sedation for Total Knee Arthroplasty in a Patient with Contraindication for General AnesthesiaCase Reports in Anesthesiology, 2015
- Early mobilization of patients who have had a hip or knee joint replacement reduces length of stay in hospital: a systematic reviewClinical Rehabilitation, 2014
- Association of Early Ambulation With Length of Stay and Costs in Total Knee ArthroplastyAmerican Journal of Physical Medicine & Rehabilitation, 2014
- I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled studyBritish Journal of Anaesthesia, 2013
- Neurotoxicity of Adjuvants Used in Perineural Anesthesia and Analgesia in Comparison With RopivacaineRegional Anesthesia & Pain Medicine, 2011
- Tribloc (fémoral, sciatique, obturateur) pour la chirurgie ambulatoire arthroscopique de genou : étude prospective de faisabilité et d’efficacitéAnnales Françaises d'Anesthésie et de Réanimation, 2010
- Does Regional Anesthesia Improve Outcome After Total Knee Arthroplasty?Clinical Orthopaedics and Related Research, 2009